|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM36163322X |
| 003 |
DE-627 |
| 005 |
20231226085543.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.202305095
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1205.xml
|
| 035 |
|
|
|a (DE-627)NLM36163322X
|
| 035 |
|
|
|a (NLM)37665594
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Cheng, Yanxiang
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Functional Materials for Subcellular Targeting Strategies in Cancer Therapy
|b Progress and Prospects
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 05.12.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status Publisher
|
| 520 |
|
|
|a © 2023 Wiley-VCH GmbH.
|
| 520 |
|
|
|a Neoadjuvant and adjuvant therapies have made significant progress in cancer treatment. However, tumor adjuvant therapy still faces challenges due to the intrinsic heterogeneity of cancer, genomic instability, and the formation of an immunosuppressive tumor microenvironment. Functional materials possess unique biological properties such as long circulation times, tumor-specific targeting, and immunomodulation. The combination of functional materials with natural substances and nanotechnology has led to the development of smart biomaterials with multiple functions, high biocompatibilities, and negligible immunogenicities, which can be used for precise cancer treatment. Recently, subcellular structure-targeting functional materials have received particular attention in various biomedical applications including the diagnosis, sensing, and imaging of tumors and drug delivery. Subcellular organelle-targeting materials can precisely accumulate therapeutic agents in organelles, considerably reduce the threshold dosages of therapeutic agents, and minimize drug-related side effects. This review provides a systematic and comprehensive overview of the research progress in subcellular organelle-targeted cancer therapy based on functional nanomaterials. Moreover, it explains the challenges and prospects of subcellular organelle-targeting functional materials in precision oncology. The review will serve as an excellent cutting-edge guide for researchers in the field of subcellular organelle-targeted cancer therapy
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a cancer therapy
|
| 650 |
|
4 |
|a functional materials
|
| 650 |
|
4 |
|a nanomedicine
|
| 650 |
|
4 |
|a precise therapy
|
| 650 |
|
4 |
|a subcellular organelles
|
| 700 |
1 |
|
|a Qu, Zhen
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jiang, Qian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xu, Tingting
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zheng, Hongyun
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ye, Peng
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a He, Mingdi
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Tong, Yongqing
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Ma, Yan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Bao, Anyu
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g (2023) vom: 04. Sept., Seite e2305095
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g year:2023
|g day:04
|g month:09
|g pages:e2305095
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202305095
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2023
|b 04
|c 09
|h e2305095
|